Literature DB >> 943223

Control of recurrent supraventricular tachycardia with amiodarone hydrochloride.

J H Swan, A W Chisholm.   

Abstract

Amiodarone hydrochloride, a new antiarrhythmic agent, controlled a recurrent supraventricular arrhythmia, refractory to conventional medical treatment, in a 57-year-old patient with an anomalous conduction system and idiopathic cardiomyopathy. For the 11 months that the patient has been taking the drug her arrhythmia has not recurred. This drug has produced no important side effects in this patient.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 943223      PMCID： PMC1956563     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


  10 in total

1.  Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment.

Authors:  S B Olsson; L Brorson; E Varnauskas
Journal:  Br Heart J       Date:  1973-12

2.  Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride.

Authors:  M B Rosenbaum; P A Chiale; D Ryba; M V Elizari
Journal:  Am J Cardiol       Date:  1974-08       Impact factor: 2.778

3.  [Thyroid insufficiency following amiodarone treatment. 2 new cases].

Authors:  J Hazard; L Perlemuter; R Bernheim; B Guilhaume; D Richier
Journal:  Nouv Presse Med       Date:  1973-03-17

4.  [The effect of amiodarone on ocular tissues].

Authors:  J Babel; N Stangos
Journal:  Schweiz Med Wochenschr       Date:  1972-02-19

5.  Pharmacology of amiodarone, and anti-anginal drug with a new biological profile.

Authors:  R Charlier; G Deltour; A Baudine; F Chaillet
Journal:  Arzneimittelforschung       Date:  1968-11

Review 6.  Comparative mechanisms of action of antiarrhythmic drugs.

Authors:  B N Singh; O Hauswirth
Journal:  Am Heart J       Date:  1974-03       Impact factor: 4.749

7.  Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.

Authors:  J M Petta; V J Zaccheo
Journal:  J Pharmacol Exp Ther       Date:  1971-02       Impact factor: 4.030

8.  [Research on the benzofuran series. XXVI. General pharmacological effects of amiodarone].

Authors:  A Baudine; F Chaillet; R Charlier; A Hosslet
Journal:  Arch Int Pharmacodyn Ther       Date:  1967-10

9.  The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

10.  Pseudocyanotic pigmentation of the skin induced by amiodarone: a light and electron microscopic study.

Authors:  C Delage; R Lagacé; J Huard
Journal:  Can Med Assoc J       Date:  1975-05-17       Impact factor: 8.262
  10 in total
  1 in total

1.  Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.

Authors:  J L Anderson; D C Harrison; P J Meffin; R A Winkle
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.